On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
2023 年 10 月 26 日，Tempest Therapeutics 收到了納斯達克的正式通知，稱該公司已恢復遵守納斯達克 1.00 美元最低價格規則
On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
2023 年 10 月 26 日，Tempest Therapeutics 收到了納斯達克的正式通知，稱該公司已恢復遵守納斯達克 1.00 美元最低價格規則